Search - tctmd.com

Displaying 381 - 400 of 649

Sort: Relevancy | Date

News Daily News

FDA Approves Dapagliflozin for CKD Patients

Michael O'Riordan

May 03, 2021

News Opinion CV Team Dispatch

May 2021 News Roundup

L.A. McKeown

May 01, 2021

News Conference News SCAI 2021

In African-American Patients, Nontraditional Risk Factors Track With Early CAD

Michael O'Riordan

April 28, 2021

News Daily News

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Michael O'Riordan

April 26, 2021

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

News Daily News

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Michael O'Riordan

April 21, 2021

News Daily News

Highest-Risk Patients Gain the Most From Intensive BP Therapy

Todd Neale

April 20, 2021

News Opinion CV Team Dispatch

April 2021 News Roundup

L.A. McKeown

April 10, 2021

News Daily News

Mobile Tech May Boost CAD Secondary Prevention for Older Adults

L.A. McKeown

April 07, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2021

Shelley Wood

April 02, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Daily News

MI Hospitalizations Down 20% at COVID-19 Peak in Italy, With a Heavy Cost

Michael O'Riordan

March 04, 2021

News Opinion CV Team Dispatch

March 2021 News Roundup

L.A. McKeown

March 01, 2021

News Daily News

CV Complications of Malaria Rare but Portend Poor Prognosis

Michael O'Riordan

February 22, 2021

News Daily News

Did Regional Differences Muddy Results in COMMANDER-HF?

L.A. McKeown

February 04, 2021

News Opinion CV Team Dispatch

February 2021 News Roundup

L.A. McKeown

February 01, 2021

News Daily News

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Michael O'Riordan

January 28, 2021

News Daily News

Vitamin D, Calcium, Other Vitamins, and Supplements Do Not Prevent CVD

Michael O'Riordan

January 25, 2021

News Daily News

FDA Approves Vericiguat for High-risk Patients With HF

Michael O'Riordan

January 20, 2021

News Daily News

REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients

Todd Neale

January 13, 2021

Advertisement

FDA Approves Dapagliflozin for CKD Patients

May 2021 News Roundup

In African-American Patients, Nontraditional Risk Factors Track With Early CAD

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Highest-Risk Patients Gain the Most From Intensive BP Therapy

April 2021 News Roundup

Mobile Tech May Boost CAD Secondary Prevention for Older Adults

TCTMD’s Top 10 Most Popular Stories for March 2021

Roughly 80% of ESC Guideline Writers Have Financial COIs

MI Hospitalizations Down 20% at COVID-19 Peak in Italy, With a Heavy Cost

March 2021 News Roundup

CV Complications of Malaria Rare but Portend Poor Prognosis

Did Regional Differences Muddy Results in COMMANDER-HF?

February 2021 News Roundup

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Vitamin D, Calcium, Other Vitamins, and Supplements Do Not Prevent CVD

FDA Approves Vericiguat for High-risk Patients With HF

REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content